Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Apogee Enterprises | APOG | Oct 16, 2024 | 79.45 | +0.81 |
Apogee Therapeutics | APGE | Oct 16, 2024 | 56.80 | +3.50 |
Apollo Commercial Real Estate Finance | ARI | Oct 16, 2024 | 8.99 | +1.47 |
Apollo Global Management | APO | Oct 16, 2024 | 142.85 | +0.92 |
Apollomics A | APLM | Oct 16, 2024 | 0.12 | -0.16 |
AppFolio A | APPF | Oct 16, 2024 | 203.34 | +0.68 |
Appian A | APPN | Oct 16, 2024 | 31.11 | +0.39 |
Apple | AAPL | Oct 16, 2024 | 231.78 | -0.89 |
Apple Hospitality REIT | APLE | Oct 16, 2024 | 15.24 | +1.53 |
Applied Digital | APLD | Oct 16, 2024 | 8.05 | +10.27 |
Applied DNA Sciences | APDN | Oct 16, 2024 | 0.31 | +7.50 |
Applied Industrial Technologies | AIT | Oct 16, 2024 | 234.39 | +3.17 |
Applied Materials | AMAT | Oct 16, 2024 | 184.59 | -3.37 |
Applied Optoelectronics | AAOI | Oct 16, 2024 | 18.97 | +9.02 |
Applied Therapeutics | APLT | Oct 16, 2024 | 8.79 | -3.77 |
Applovin A | APP | Oct 16, 2024 | 144.85 | +0.72 |
AppTech Payments | APCX | Oct 16, 2024 | 0.72 | +3.94 |
Aprea Therapeutics | APRE | Oct 16, 2024 | 3.50 | +14.75 |
AptarGroup | ATR | Oct 16, 2024 | 166.04 | -1.57 |
Aptevo Therapeutics | APVO | Oct 16, 2024 | 0.16 | +7.11 |
Aptiv | APTV | Oct 16, 2024 | 70.36 | +0.51 |
Aptorum Group A | APM | Oct 16, 2024 | 1.69 | -4.09 |
Aptose Biosciences | APTO | Oct 16, 2024 | 0.37 | +2.11 |
APx Acquisition I A | APXI | Oct 16, 2024 | 11.72 | 0.00 |
APx Acquisition I Unit | APXIU | Oct 16, 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | Oct 16, 2024 | 1.23 | +4.24 |
Aqua Metals | AQMS | Oct 16, 2024 | 0.16 | +2.50 |
AquaBounty Technologies | AQB | Oct 16, 2024 | 1.20 | +0.42 |
Aquaron Acquisition | AQU | Oct 16, 2024 | 11.00 | 0.00 |
Aquaron Acquisition Units | AQUNU | Oct 16, 2024 | 11.15 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.